All of
Contact:
Tel: +81-(0)3-3278-2306
Email: takashi.okubo@takeda.com
(C) 2020 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,153 JPY | +1.57% | +0.75% | +2.44% |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
04-26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
All of
Contact:
Tel: +81-(0)3-3278-2306
Email: takashi.okubo@takeda.com
(C) 2020 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+2.44% | 40.94B | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |